Stocks and Investing Stocks and Investing
Wed, March 22, 2023
Tue, March 21, 2023
Mon, March 20, 2023
Sat, March 18, 2023
Fri, March 17, 2023

Jonathan Wolleben Maintained (SPRB) at Buy and Held Target at $7 on, Mar 17th, 2023


Published on 2024-10-28 02:19:07 - WOPRAI, Jonathan Wolleben
  Print publication without navigation


Jonathan Wolleben of JMP Securities, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $7 on, Mar 17th, 2023.

Jonathan has made no other calls on SPRB in the last 4 months.



There are 2 other peers that have a rating on SPRB. Out of the 2 peers that are also analyzing SPRB, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jonathan


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $8 on, Monday, February 13th, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $8 on, Thursday, November 17th, 2022